Olfen Hydrożel (Diclofenac Sodium)

Diclofenac sodium blocks the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are needed to produce prostaglandins. By lowering prostaglandin levels at the site of application, the gel reduces inflammation, pain and swelling locally without significant systemic absorption.

The prescribed amount of Olfen Hydrożel is determined by a healthcare professional based on the patient’s condition, age and treatment area. The prescriber will advise how much gel to apply and how often, typically a thin layer to the affected skin several times daily.

Topical diclofenac should be used during pregnancy or breastfeeding only if clearly needed and after consulting a healthcare provider. Systemic absorption is low, but caution is advised, especially in the third trimester and while nursing, to avoid potential fetal or infant exposure.

To order Olfen Hydrożel, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Olfen Hydrożel delivers diclofenac sodium, a potent COX‑inhibitor, in a hydrogel base that provides rapid skin absorption. Compared with gels containing ibuprofen or ketoprofen, diclofenac often offers stronger anti‑inflammatory effects, though individual response varies and choice depends on clinician preference and patient tolerance.

Olfen Hydrożel should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and extreme heat to maintain gel consistency and potency.

Apply a thin layer of the gel to clean, dry, intact skin over the painful area and gently rub it in. Follow the prescriber’s instructions regarding frequency, usually two to four times per day, and avoid covering the treated area with airtight dressings unless directed.

Serious risks include severe allergic skin reactions such as contact dermatitis, systemic NSAID effects like gastrointestinal bleeding, and potential kidney or liver function changes, especially in patients with pre‑existing organ disease or who use other NSAIDs concurrently.

Individuals with a known hypersensitivity to diclofenac, other NSAIDs, or any component of the gel should avoid its use. It is also contraindicated in patients with active gastrointestinal ulcers, severe heart failure, or uncontrolled renal or hepatic impairment unless specifically directed by a physician.